Text Size

Association Between Schizophrenia and Cancer

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00419016
First received: January 4, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
  Purpose

A family study of the negative association betweeen schizophrenia and cancer


Condition
Schizophrenia
Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective

Resource links provided by NLM:

MedlinePlus related topics: Cancer Schizophrenia
U.S. FDA Resources

Further study details as provided by Sheba Medical Center:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • schizophrenia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00419016

Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Gilad Gal, PhD The Gertner Institute for Epidemiology and Health Policy Research
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00419016     History of Changes
Other Study ID Numbers: SHEBA-06-4489-RG-CTIL
Study First Received: January 4, 2007
Last Updated: January 4, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013